Articles by P Carpentier (2)

Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer

C. N Sternberg, H Dumez, H Van Poppel, I Skoneczna, A Sella, G Daugaard, T Gil, J Graham, P Carpentier, F Calabro, L Collette, D Lacombe and for the EORTC Genitourinary Tract Cancer Group

Annals of Oncology 20 ( 7 ): 1264 - 1269 , 2009

Should Plasma Homocysteine Be Used as a Biomarker of Venous Thromboembolism? A Case--Control Study

V Ducros, C Barro, J Yver, G Pernod, B Polack, P Carpentier, M. D Desruet and J. L. Bosson

Clinical and Applied Thrombosis/Hemostasis 15 ( 5 ): 517 - 522 , 2009

Do you have a suggestion for journals

Suggest Journal